한글목차

미국의 혈우병 A 시장에 대해 조사분석했으며, 일부 혈우병 A 치료제의 높은 로열티와 만족도의 이유 및 의사의 선택을 촉진하는 요인, 주요 브랜드의 비교 등의 인사이트를 제공하고 있습니다.

리포트 내용

• 각 브랜드의 NPS 스코어 비교
• 의사는 특정 브랜드에 대한 충성도가 어느 정도인가?
• 의사들이 공감하는 브랜드 메시지는 무엇인가?
• 의사의 선택을 촉진하는 주요 요인은?
• 주요 브랜드의 시장 점유율
• 각 주요 브랜드의 경쟁사와의 비교
• 브랜드 만족도가 낮아 교체할 수 있는 브랜드

주요 브랜드

영문목차

There are various options available to US haematologists treating haemophilia A. Clearly some of these options are achieving greater levels of loyalty and satisfaction than others - but why? What are the key factors driving physician choice and how does each of the leading brands compare to its competitors? Gain insights into various haemophilia A therapies in the US.

Key Questions Answered:

• 1. How do NPS scores by brand compare?
• 2. How loyal are physicians to specific brands?
• 3. What brand messages resonate with physicians?
• 4. What are the key factors driving physician choice?
• 5. What is the market share of leading brands?
• 6. How does each of the leading brands compare to its competitors?
• 7. Which brands are vulnerable to switching due to low brand satisfaction?

Key Brands:

Methodology:

FirstView reports are developed from quantitative surveys conducted with physicians selected through LiMATM, the world's largest physician directory, containing over 3 million vetted and verified physicians. Each physician is carefully chosen based on strict screening criteria to ensure the insights gathered are both relevant and reliable, reflecting the true sentiments and experiences of leading medical professionals. The findings are presented in a series of easy-to-interpret charts, enabling you to quickly grasp and analyze the data. By leveraging the vast reach and precision of LiMATM, FirstView Reports provide unparalleled, data-driven insights to guide your strategic planning and help you stay ahead in a fast-evolving healthcare landscape.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.